Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of December 2025 for Haleon Plc, a global leader in consumer health. The report details corporate governance updates regarding the Board of Directors and committee structures effective January 2026.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on board composition changes and does not contain financial performance data.
Material Changes
- Leadership Transition: Vindi Banga will be appointed Chair of the Board effective January 1, 2026.
- Senior Independent Director (SID): Alan Stewart will succeed Vindi Banga as SID upon the Chair appointment.
- Committee Roles: Alan Stewart will remain Chair of the Audit & Risk Committee and retain membership on the Remuneration, Nominations & Governance, and Environmental & Social Sustainability Committees.
- Committee Exits: Vindi Banga will step down from the Audit & Risk Committee and the Remuneration Committee effective December 31, 2025.
- New Committee Role: Vindi Banga will be appointed Chair of the Nominations & Governance Committee effective January 1, 2026.
Guidance, Outlook, and Compensation
The filing confirms Vindi Banga's remuneration as Chair will be £757,103 per annum. Further details regarding this compensation will be disclosed in the Company's 2025 Annual Report & Accounts. The Company states there is no further information to be disclosed under UK Listing Rule 6.4.6R. No financial guidance or operational outlook is provided in this specific filing.
Key Facts for Investor Verification
- Confirm the effective date of Vindi Banga's Chair appointment (January 1, 2026).
- Verify Alan Stewart's new role as Senior Independent Director.
- Review the 2025 Annual Report & Accounts for full details on the Chair's remuneration package.
- Note that this filing contains no financial performance data for the period.